Pds Biotechnology Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$0.77

-0.03 (-3.91%)

As of Sep 28, 10:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,542.6% upside

Low Target $11.64

Average Target $20.24

High Target $22.20

Current Price $0.77

Current
$0.77

Target
$20.24

$11.64 $20.24 avg $22.20

Scenario Analysis

Bear Case

$11.64

1,419.8%

Low target

Base Case

$20.24

+2,542.6%

Avg target

Bull Case

$22.20

+2,798.6%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$1.55

-50.6% from high

52-Week Low

$0.20

+292.4% from low

Target vs 52W High

$20.24

+1,205.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%